Newer, more resistance organisms develop, and newer, more potent antibiotics are created. What are some of the organisms that we are seeing in patient care settings, and what treatments are being developed to combat these bacteria? Differences in care relating to modality and to glomerular filtration rate are also reviewed.
Contact hours available until 9/22/2015.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Conflict of Interest Disclosure: Speaker(s) have no disclosures to declare.
Conference Committee Disclosures: Dawn Koonkongsatian – Employee, Fresenius Medical Care Kristin Larson – Employee, NxStage Medical Denise Murcek – Employee, Fresenius Medical Care Beth St. John - Employee, Fresenius Medical Care Lucy Todd – Employee, Baxter Healthcare Kyra Trappett – Employee, DaVita
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Analyze current and future trends in infections in persons with CKD.
Examine pharmacology management in persons with infections.
Determine dosing strategies based upon estimated GFR and treatment modality.